Senior Director, WW Medical, Early Differentiation and Pipeline Lead

Working with Us
Challenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it. You’ll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams rich in diversity. Take your career farther than you thought possible.

Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives. Read more: careers.bms.com/working-with-us.

Position Summary

This position plays a critical role in the development and execution of BMS’ global medical strategy for: 1) set of assets within our Immunology, Cardiovascular and Neurology (ICN) early development portfolios & 2) input to translational medicine plans across the ICN portfolios. The WWM EDAP Lead is a strategic leader within Worldwide Medical organization, accountable to the EA Development teams. The Lead will support development plans via interpretation of evolving pre-clinical & clinical data, develop a sustainable Integrated Evidence Plan & engage with TLs (researchers & clinicians) early and often during pre-POC phase of asset lifecycles. This individual will hold accountability for advancing scientific narrative, thought leader engagement, and staying abreast of evolution of early phase research and competitive landscape. This individual will leverage insights from patient journeys to further define strategies that drive the development of clinically differentiated compounds. The matrix leader will communicate/present EA portfolio to partners and customers (internal & external).

Key Responsibilities

• This position plays a critical role in ensuring the clinical differentiation of BMS’ ICN Early Assets across the ICN portfolio. Development and execution of medical differentiation plans is executed across 4 domains: 1) Insight gathering and integration; 2) Evidence generation; 3) Medical Communications; 4) Patient Journey. This leader owns the EA medical strategy, including medical evidence generation plans, development of scientific narrative & creation of the integrated evidence plans to advance asset development. This position includes the following responsibilities:

• Develop and execute medical differentiation plans for assigned compounds across 4 domains: 1) Insight gathering and integration; 2) Evidence generation; 3) Medical Communications; 4) Patient Journey

• Be a critical partner to Early Asset Development Program Leads, Clinical Development Leads, ICN Medical/Commercial teams, and Translational Medicine to ensure medical readiness and to deliver against objectives and program milestones, as a core member of the early GPTs

• Serve as a primary source of Medical accountability for a set of early assets; matrix management responsibilities across the internal network (Commercial, R&D, Medical, & Access)

• Ensure the development of a clearly differentiated TPP for each early asset

• Own the Integrated Evidence Plans (IEP) to complement data generation with Early Drug Development & ongoing evaluation of IST/ITT/strategic collaboration proposals, including medical biomarker and TM components

• Develop innovative Early Asset internal and external medical education presentations, programs, and training

• Partner with external Thought Leaders (on ongoing basis) to gain medical advice on Early Asset compound strategies, with a goal to inform asset decision making and portfolio tradeoffs

• Be the voice of Medical to inform and accelerate decision making and governance for assigned compounds

• Support asset / study level objectives (protocol development, study start-up, enrollment & engagement)

• Work with publications and colleagues from across the business to develop and execute a robust publication strategy

• Partner with the Translational Medicine & Diagnostic and Commercial on precision medicine strategy for ICN

• Exercise enterprise mindset with ability to work in highly matrixed environment

• Be a science-driven Medical Affairs professional with high business acumen